Description
The purpose of this Notice of Amendment is to notify about the additions of: Elexacaftor, Inclisiran, Ospemifene, Pralsetinib and Tafasitamab to the Prescription Drug List (PDL) for human and veterinary use, and Frunevetmab to the PDL for veterinary use.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10) | HTML | Open resource | |
| Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10) | HTML | Open resource |